coronavirus briefing india & the coronavirus: modelling the … · distribution of covid-19 related...

57
Coronavirus Briefing India & the Coronavirus: Modelling the Trajectory of Covid-19 Bhramar Mukherjee & the COV-IND-19 Study Group Webinar, Friday, April 10, 2020, 5:30 p.m. IST

Upload: others

Post on 21-May-2020

4 views

Category:

Documents


0 download

TRANSCRIPT

  • Coronavirus Briefing

    India & the Coronavirus:Modelling the Trajectory of Covid-19

    Bhramar Mukherjee & the COV-IND-19 Study Group

    Webinar, Friday, April 10, 2020, 5:30 p.m. IST

  • !"#$%&'%()*+,"(-#,(.,%)'#"/#)'%()*,0)$,%12-%&0'%()*,(.,0,345$06,-(&7$(8),(),'9#,:;54?,(@'A"#07,%),=)$%0

    !"#$%&'$()*+,-./*012-3

    !

    !"#$"%&'($)*$+,$"-'.#)%/(.#0'1/+#12#(-%-#)*$&"%$)%)

    !"#$%&'()*+,-./-*0&12.&3232

  • !"#$%&'()'&"*+%++&,

    -%*"&'.%,/&,

    0&&,%(.%'%1%*1%234$%5%*"

    !63+37".%*&,8&&(

    935%7.$%44%#$%,22%(

    -&:,%8.6+&

    ;%,"/+$"4(

  • !"#$%&'()*+,-+.

    !"#$%&'()'("*'+,-&('-*&.)$/*-&')+'0123456'7-,&,&'#-)8$/'("*'9)-:/;

    !"#$#%&$"#'()&(*+,)-.'!/0.(1&2#11/+/&1#*3#*

    !"#$%&'()*+*+)",#-.,$#/0,$%)102,3/%)04)52.6-6)!"15'

    !!!"#$%&'(%)*"+,-

    !17/,$')8889:/,72$,-#930; !",

  • !"#"$"%&"'()*(*+$(,*$-

    "

    5&($/7#!'%$*,"#5-'*6#89

    5&($/7#!'%$*,!+'$,#:#

    !"#$%&'()*#%*'+#,%+-.-%.)-$&"-)#$*/%-$+%*'001.0#$.%.'%)#")'+(*123#%&*1#$*#4%*'51$+678')9

    https://medium.com/@covind_19/predictions-and-role-of-interventions-for-covid-19-outbreak-in-india-52903e2544e6https://medium.com/@covind_19/historic-lockdown-prediction-models-to-study-lockdown-effects-and-the-role-of-data-in-the-crisis-a0afeeec5a6http://covind19.org/

  • Outline

    • Pre-lockdown forecasting

    • Post-lockdown analysis

    • Epidemiologic models: All are wrong, some are useful

    • From numerical forecasting to strategic vision

    5

  • 12"%(,"(')3$)"4()20'(,*$-

    $%&'()*+,!""#$%&&'''(#!)*+),-."/,)01"-,!230345(,3+&2-'$&/26/)1,37/61891,3*32)7/*.$1.#6)"-$1$")".$1:51$")"-&

    0

    10

    20

    30

    40Ja

    n.30

    Feb.

    02

    Feb.

    03

    Feb.

    16

    Mar

    .02

    Mar

    .04

    Mar

    .05

    Mar

    .06

    Mar

    .07

    Mar

    .08

    Mar

    .09

    Mar

    .10

    Mar

    .11

    Mar

    .12

    Mar

    .13

    Mar

    .14

    Mar

    .15

    Mar

    .16

    Mar

    .17

    Mar

    .18

    Mar

    .19

    DeathRecoveredCase

    Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in India

    Couple cases,no intervention

    Sudden case increase,screening & travel bans start

    Social distancing, closures,more travel bans

    Heading towardslockdown

    WHO declarespandemic

    First case

    © COV-IND-19 Study Group

    https://www.pharmaceutical-technology.com/news/india-covid-19-coronavirus-updates-status-by-state/

  • Distribution of COVID-19 related risk factors

    7

    5

    to support the sheer volume of cases. India has the most overstretched healthcare s stem here it is hard to pro ide care in times of normal patient volume. The number of hospital beds per 1000 people in India is only 0.7, compared to 6.5 in France, 11.5 in South Korea, 4.2 in China, 3.4 in Italy, 2.9 in the UK, 2.8 in the USA, and 1.5 in Iran [World Bank]. Need to emphasize that health care workers and front-line workers are among the most vulnerable.

    Table 2. Proportion of population in specifically vulnerable subgroups at potentially high risk of COVID-19 severity risk in India

    Metric Number†

    (in millions) Year Source

    Uninsured 1,104 2014 Prinja et al. 2019

    Population over 65 92.5 2020 (est.) CIA World Factbook

    Hypertension (men)* 175.7 2015/16 Gupta & Ram 2019

    Hypertension (women)* 132.6 2015/16 Gupta & Ram 2019

    People with cardiovascular disease* 78.7 2016 Prabhakaran et al. 2018

    Population with COPD* 75.9 2016 Lancet 2018

    Population with asthma* 45.5 2016 Lancet 2018

    Develop cancer by age 75 (men)** 70.3 2018 NICPR

    Develop cancer by age 75 (men)** 62.3 2018 NICPR

    Population with diabetes (adult) 122.8 - IDF

    Access to inpatient department facilities*** 731.4 2012 IMS Institute 2013

    Access to outpatient department*** 1,104 2012 IMS Institute 2013

    † based on 2020 est. of 1.38 billion from UN Department of Economic and Social Affairs * age-standardized; ** risk; *** defined as within 5 kilometer distance of home or work Abbrev.: COPD, chronic obstructive pulmonary disease; IDF, International Diabetes Federation; NICPR, National Institute of Cancer Prevention and Research

    3. Do interventions like travel bans and social distancing help arrest the projected exponential growth of COVID-19?

    Yes! We took a close look at what might be coming in the next few weeks and months, based on what we have seen in other countries and an improved epidemiological model that have been gainfully employed to

  • =$":/*&-4*,%(#*$"&3')

    .

    Forecast after Mar.16

    Upper credible limit of predicted cases for India

    * indicates any observed value after Mar.16

    1

    7

    50

    354

    2507

    17735

    125490

    887930

    6282715

    44454503

    1

    7

    50

    354

    2507

    17735

    125490

    887930

    6282715

    44454503

    Feb.

    01Fe

    b.02

    Feb.

    03Fe

    b.04

    Feb.

    05Fe

    b.06

    Feb.

    07Fe

    b.08

    Feb.

    09Fe

    b.10

    Feb.

    11Fe

    b.12

    Feb.

    13Fe

    b.14

    Feb.

    15Fe

    b.16

    Feb.

    17Fe

    b.18

    Feb.

    19Fe

    b.20

    Feb.

    21Fe

    b.22

    Feb.

    23Fe

    b.24

    Feb.

    25Fe

    b.26

    Feb.

    27Fe

    b.28

    Feb.

    29M

    ar.0

    1M

    ar.0

    2M

    ar.0

    3M

    ar.0

    4M

    ar.0

    5M

    ar.0

    6M

    ar.0

    7M

    ar.0

    8M

    ar.0

    9M

    ar.1

    0M

    ar.1

    1M

    ar.1

    2M

    ar.1

    3M

    ar.1

    4M

    ar.1

    5M

    ar.1

    6M

    ar.1

    7M

    ar.1

    8M

    ar.1

    9M

    ar.2

    0M

    ar.2

    1M

    ar.2

    2M

    ar.2

    3M

    ar.2

    4M

    ar.2

    5M

    ar.2

    6M

    ar.2

    7M

    ar.2

    8M

    ar.2

    9M

    ar.3

    0M

    ar.3

    1Ap

    r.01

    Apr.0

    2Ap

    r.03

    Apr.0

    4Ap

    r.05

    Apr.0

    6Ap

    r.07

    Apr.0

    8Ap

    r.09

    Apr.1

    0Ap

    r.11

    Apr.1

    2Ap

    r.13

    Apr.1

    4Ap

    r.15

    Apr.1

    6Ap

    r.17

    Apr.1

    8Ap

    r.19

    Apr.2

    0Ap

    r.21

    Apr.2

    2Ap

    r.23

    Apr.2

    4Ap

    r.25

    Apr.2

    6Ap

    r.27

    Apr.2

    8Ap

    r.29

    Apr.3

    0M

    ay.0

    1M

    ay.0

    2M

    ay.0

    3M

    ay.0

    4M

    ay.0

    5M

    ay.0

    6M

    ay.0

    7M

    ay.0

    8M

    ay.0

    9M

    ay.1

    0M

    ay.1

    1M

    ay.1

    2M

    ay.1

    3M

    ay.1

    4M

    ay.1

    5

    India US Italy

    COVID!19 Cumulative Confirmed Cases by Day

    © COV!IND!19 Study Group

  • >"403((&*?"$3@"

    /

  • !"#$%&"'()*+,-.(/-$"%0-1(2%'3,%405(6-&'7()8

    !0!"#$%"&'()("%*$)+,&-('.#(/"&0)$112),&23(#+,&(4&5$1)%"0&/().2),&0(&)+)%-&%)2%,&6407'(58

    9$--$(",&-$1:0&'%"#-2,&$"&%&'(--2'0$*2$,;-%

  • Lockdown simply buys us time• To ramp up testing, disease surveillance, contact network tracing

    • Prepare healthcare infrastructure

    • Optimally deploy resources based on emerging hotspots

    • Stop the virus: pause and then revive the economy

    • Keeping the essential supply chain going and support the vulnerable

    • Long-term strategy: instead of discrete short-term tactics 11

  • !1

    45.*5*36789,*:9;79

    &99.*,2*5,7?*,2>91@A*.5B@A*9@7539*

  • Questions that one can pose

    • How many cases do we expect to see post lockdown?

    • When can we expect to see a decline in fatalities?

    • What does a successful lockdown look like?

    • How should we return to normalcy from lockdown?

    13

  • E+3/0)3)0?"(&*BC3$0'*%(: F+6"0G(720%3

    !"

    Lock

    dow

    n fro

    m J

    an.2

    3Lo

    ckdo

    wn

    from

    Jan

    .23

    Lock

    dow

    n fro

    m J

    an.2

    3Lo

    ckdo

    wn

    from

    Jan

    .23

    Lock

    dow

    n fro

    m J

    an.2

    3Lo

    ckdo

    wn

    from

    Jan

    .23

    Lock

    dow

    n fro

    m J

    an.2

    3

    0

    5000

    10000

    15000Ja

    n.22

    Jan.

    24Ja

    n.25

    Jan.

    26Ja

    n.27

    Jan.

    28Ja

    n.29

    Jan.

    30Ja

    n.31

    Feb.

    01Fe

    b.02

    Feb.

    03Fe

    b.04

    Feb.

    05Fe

    b.06

    Feb.

    07Fe

    b.08

    Feb.

    09Fe

    b.10

    Feb.

    11Fe

    b.12

    Feb.

    13Fe

    b.14

    Feb.

    15Fe

    b.16

    Feb.

    17Fe

    b.18

    Feb.

    19Fe

    b.20

    Feb.

    21Fe

    b.22

    Feb.

    23Fe

    b.24

    Feb.

    25Fe

    b.26

    Feb.

    27Fe

    b.28

    Feb.

    29M

    ar.0

    1M

    ar.0

    2M

    ar.0

    3M

    ar.0

    4M

    ar.0

    5M

    ar.0

    6M

    ar.0

    7M

    ar.0

    8M

    ar.0

    9M

    ar.1

    0M

    ar.1

    1M

    ar.1

    2M

    ar.1

    3M

    ar.1

    4M

    ar.1

    5M

    ar.1

    6M

    ar.1

    7M

    ar.1

    8M

    ar.1

    9M

    ar.2

    0M

    ar.2

    1M

    ar.2

    2M

    ar.2

    3M

    ar.2

    4M

    ar.2

    5M

    ar.2

    6M

    ar.2

    7M

    ar.2

    8M

    ar.2

    9M

    ar.3

    0M

    ar.3

    1A

    pr.0

    1A

    pr.0

    2A

    pr.0

    3A

    pr.0

    4A

    pr.0

    5A

    pr.0

    6A

    pr.0

    7A

    pr.0

    8A

    pr.0

    9

    DeathRecoveredCase

    Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in Hubei, China

    Only lockdownin place

    Lockdown, Centralized treatment& isolation strategies

    Lockdown liftedin most of Hubei

    © COV-IND-19 Study Group

  • E+3/0)3)0?"(&*BC3$0'*%(: H*+)2(I*$"3

    !#

    0

    500

    1000

    1500Fe

    b.01

    Feb.

    02Fe

    b.04

    Feb.

    05Fe

    b.06

    Feb.

    07Fe

    b.09

    Feb.

    10Fe

    b.11

    Feb.

    12Fe

    b.15

    Feb.

    16Fe

    b.17

    Feb.

    18Fe

    b.20

    Feb.

    21Fe

    b.22

    Feb.

    23Fe

    b.24

    Feb.

    25Fe

    b.26

    Feb.

    27Fe

    b.28

    Feb.

    29M

    ar.0

    1M

    ar.0

    2M

    ar.0

    3M

    ar.0

    4M

    ar.0

    5M

    ar.0

    6M

    ar.0

    7M

    ar.0

    8M

    ar.0

    9M

    ar.1

    1M

    ar.1

    2M

    ar.1

    3M

    ar.1

    4M

    ar.1

    5M

    ar.1

    6M

    ar.1

    7M

    ar.1

    8M

    ar.1

    9M

    ar.2

    0M

    ar.2

    1M

    ar.2

    2M

    ar.2

    3M

    ar.2

    4M

    ar.2

    5M

    ar.2

    6M

    ar.2

    7M

    ar.2

    8M

    ar.2

    9M

    ar.3

    0M

    ar.3

    1A

    pr.0

    1A

    pr.0

    2A

    pr.0

    3A

    pr.0

    4A

    pr.0

    5A

    pr.0

    6A

    pr.0

    7A

    pr.0

    8A

    pr.0

    9

    DeathRecoveredCase

    Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in South Korea

    No lockdown; extensive testing, drive-through testing & contact tracing the whole time;voluntary social distancing and self-quarantine recommended

    © COV-IND-19 Study Group

  • E+3/0)3)0?"(&*BC3$0'*%(: 9)3/D

    !$

    Lock

    dow

    n fro

    m M

    ar.0

    9Lo

    ckdo

    wn

    from

    Mar

    .09

    Lock

    dow

    n fro

    m M

    ar.0

    9Lo

    ckdo

    wn

    from

    Mar

    .09

    Lock

    dow

    n fro

    m M

    ar.0

    9Lo

    ckdo

    wn

    from

    Mar

    .09

    Lock

    dow

    n fro

    m M

    ar.0

    9

    0

    2500

    5000

    7500

    Feb.

    01Fe

    b.07

    Feb.

    21Fe

    b.22

    Feb.

    23Fe

    b.24

    Feb.

    25Fe

    b.26

    Feb.

    27Fe

    b.28

    Feb.

    29M

    ar.0

    1M

    ar.0

    2M

    ar.0

    3M

    ar.0

    4M

    ar.0

    5M

    ar.0

    6M

    ar.0

    7M

    ar.0

    8M

    ar.0

    9M

    ar.1

    0M

    ar.1

    1M

    ar.1

    3M

    ar.1

    4M

    ar.1

    5M

    ar.1

    6M

    ar.1

    7M

    ar.1

    8M

    ar.1

    9M

    ar.2

    0M

    ar.2

    1M

    ar.2

    2M

    ar.2

    3M

    ar.2

    4M

    ar.2

    5M

    ar.2

    6M

    ar.2

    7M

    ar.2

    8M

    ar.2

    9M

    ar.3

    0M

    ar.3

    1A

    pr.0

    1A

    pr.0

    2A

    pr.0

    3A

    pr.0

    4A

    pr.0

    5A

    pr.0

    6A

    pr.0

    7A

    pr.0

    8A

    pr.0

    9

    DeathRecoveredCase

    Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in Italy

    Travel bans, state of emergency,quarantine zones

    National quarantine Complete lockdown

    © COV-IND-19 Study Group

  • E+3/0)3)0?"(&*BC3$0'*%(: 9%403

    !-

    Lock

    dow

    n fro

    m M

    ar.2

    5Lo

    ckdo

    wn

    from

    Mar

    .25

    Lock

    dow

    n fro

    m M

    ar.2

    5Lo

    ckdo

    wn

    from

    Mar

    .25

    Lock

    dow

    n fro

    m M

    ar.2

    5Lo

    ckdo

    wn

    from

    Mar

    .25

    0

    500

    1000

    Feb.

    01Fe

    b.02

    Feb.

    03Fe

    b.16

    Mar

    .02

    Mar

    .04

    Mar

    .05

    Mar

    .06

    Mar

    .07

    Mar

    .08

    Mar

    .09

    Mar

    .10

    Mar

    .11

    Mar

    .12

    Mar

    .13

    Mar

    .14

    Mar

    .15

    Mar

    .16

    Mar

    .17

    Mar

    .18

    Mar

    .19

    Mar

    .20

    Mar

    .21

    Mar

    .22

    Mar

    .23

    Mar

    .24

    Mar

    .25

    Mar

    .26

    Mar

    .27

    Mar

    .28

    Mar

    .29

    Mar

    .30

    Mar

    .31

    Apr

    .01

    Apr

    .02

    Apr

    .03

    Apr

    .04

    Apr

    .05

    Apr

    .06

    Apr

    .07

    Apr

    .08

    Apr

    .09

    DeathRecoveredCase

    Data source: Johns Hopkins University CSSECOVID-19 Confirmed New Cases/Recovered/Deaths by Day in India

    Couple cases,no intervention

    Sudden case increase,screening & travel bans start

    Social distancing,closures

    Heading towardslockdown

    Lockdown

    © COV-IND-19 Study Group

  • Forecasting Models (India specific)

    • ICMR• Cambridge• Armed Forces• Sourish Das (CMI)• Ohio State University

    18

    https://www.ncbi.nlm.nih.gov/pubmed/32202261https://arxiv.org/abs/2003.12055https://www.sciencedirect.com/science/article/pii/S0377123720300605https://arxiv.org/pdf/2004.03147.pdfhttps://www.medrxiv.org/content/10.1101/2020.04.02.20051466v1

  • H9!(B*4"/M(#+%43B"%)3/'

    4 !"#$%"$#&'($,8I&/(-=7+&*=&*+&7+(&7I-((&J=>,>(=KL

    !/

    ;/)*&+%$-,+=A*==*7+=&C=*+?&87C+>&:,>,L4 -./++&01&'(M-C(&/-7/7->*7+=&C+9+7;+N

    @ @ @

  • J3&0%@()2"(&23//"%@"M("N)"%4"4(H9!

    10

    4 23&/'(O+>-7:C8(&,&0,>(+>&P,-97E&/-78(==L

    A-"0#&%#-,4#89894#&;=> +-*B-0"#>#C>!D#

  • eSIR model: hierarchical formulation and solution

    !"!"

    !#= −𝛽𝜃#$𝜃#%,

    !"!#

    !#= 𝛽𝜃#$𝜃#% − 𝛾𝜃#%,

    !"!$

    !#= 𝛾𝜃#%.

    𝑌#%|𝜽𝒕, 𝝉 ∼ 𝐵𝑒𝑡𝑎(𝜆%𝜃#% , 𝜆% 1 − 𝜃#% ),𝑌#'|𝜽𝒕, 𝝉 ∼ 𝐵𝑒𝑡𝑎(𝜆'𝜃#' , 𝜆' 1 − 𝜃#' ).

    𝜽𝒕|𝜽𝒕(𝟏, 𝝉 ∼ 𝐷𝑖𝑟𝑖𝑐ℎ𝑙𝑒𝑡(𝜅𝑓(𝜽𝒕(𝟏, 𝛽, 𝛾)).

    • Given the values at the previous step, the system can then be solvedfor 𝑓 using approximations.

    21

    Compartmental Specification

    Building autocorrelation

    Reff= 𝛽/𝛾

  • Bayesian specification and Markov chain Monte Carlo (MCMC) sampling

    • Priors: 𝜽𝟎~𝐷𝑖𝑟𝑖𝑐ℎ𝑙𝑒𝑡(1 − 𝑌"# − 𝑌"$, 𝑌"#, 𝑌"$), 𝜃%& = 1 − 𝜃%# − 𝜃%$.• Can set priors/initial choices for 𝑅%, 𝛾 in data dependent way.• Begin with large variances that can be tuned with more data

    coming in.𝜅, 𝜆#, 𝜆$~𝐺𝑎𝑚𝑚𝑎 2, 0.0001 𝑖𝑖𝑑.

    • Learn the SIR dynamics from the observed data first, and then use MCMC to iterate between latent and observed proportions.

    22

  • >*4"/0%@(0%)"$?"%)0*%'

    12

    !"!"

    !#! "#

  • Forecasting scenarios and assumptions

    • No intervention• Social distancing and travel ban (without lockdown)

    Post-lockdown• 21-day lockdown with gradual resumption of activities at

    different levels:• Moderate • Cautious • Normal (pre-intervention)

    24

  • R0 under two hypothetical scenarios

    25

    Lockdown begins Lockdown ends

    0.0

    0.5

    1.0

    1.5

    2.0

    Mar 01 Apr 01 May 01Date

    Impl

    ied

    R0

    Scenario

    Cautious return

    Moderate return

    Normal (pre−intervention)

    Soc. Dist. + Travel Ban

    quick adherence (1−week delay)

    R0 over time by scenario

    © COV−IND−19 Study Group

    Lockdown begins Lockdown ends

    0.0

    0.5

    1.0

    1.5

    2.0

    Mar 01 Apr 01 May 01Date

    Impl

    ied

    R0

    Scenario

    Cautious return

    Moderate return

    Normal (pre−intervention)

    Soc. Dist. + Travel Ban

    slow adherence (2−week delay)

    R0 over time by scenario

    © COV−IND−19 Study Group

    quick

    slow

  • H2*$)()"$B(O P+0&-(342"$"%&"

    1$

    Observed

    No intervention

    Social distancing

    Lockdown with moderate release

    1

    10

    100

    1,000

    10,000

    100,000

    1,000,000

    1

    10

    100

    1,000

    10,000

    100,000

    1,000,000

    Mar 0

    1

    Mar 1

    5Ap

    r 01

    Apr 1

    5

    May 0

    1

    Date

    Cum

    ulat

    ive n

    umbe

    r of c

    ases

    as of 07 April 2020COVID!19 Cumulative Cases by Day for India

    © COV!IND!19 Study Group

    =5,"'(GH(&+4"7%4& I55&,('"7"4

    3&,456*(7*564&5 !"#$%&' ($(''$&&(%&)489,:4;685)45< &)$*(! ())$""+=&)>:&?5,@A&:*(86*B '$+%+ #($(&"

  • H2*$)()"$B(O '/*,(342"$"%&"

    1-

    Observed

    No intervention

    Social distancing

    Lockdown with moderate release

    1

    10

    100

    1,000

    10,000

    100,000

    1,000,000

    1

    10

    100

    1,000

    10,000

    100,000

    1,000,000

    Mar 0

    1

    Mar 1

    5Ap

    r 01

    Apr 1

    5

    May 0

    1

    Date

    Cum

    ulat

    ive n

    umbe

    r of c

    ases

    as of 07 April 2020COVID!19 Cumulative Cases by Day for India

    © COV!IND!19 Study Group

    =5,"'(GH(&+4"7%4& I55&,('"7"4

    3&,456*(7*564&5 !"#$%&' ($(''$&&(

    %&)489,:4;685)45< "&$#(% !!($*!(

    =&)>:&?5,@A&:*(86*B ++,-.- %&$(%"

  • Long term – quick adherence

    28

    Difference between social distancing andcautious return on May 15: 343,145 cases

    Difference between social distancing andcautious return on June 15: 2,376,468 cases

    Difference between social distancing andcautious return on July 15: 4,589,917 cases

    0

    200

    400

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f inf

    ecte

    d ca

    ses

    per 1

    00,0

    00 p

    eopl

    e in

    Indi

    a ScenarioCautious return

    Moderate return

    Normal (pre−intervention)

    Soc. Dist. + Travel Ban

    as of 07 April 2020Predicted number of COVID−19 cases in India under hypothetical scenarios

    © COV−IND−19 Study Group

    Cautious 5/15: 16,520 Cautious 6/15: 251,636 Cautious 7/15: 927,407

  • Long term – quick adherence

    29

    Difference between social distancing andcautious return on May 15: 36,062 cases

    Difference between social distancing andcautious return on June 15: 79,492 cases

    Difference between social distancing andcautious return on July 15: 65,018 cases

    0

    3

    6

    9

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f new

    cas

    es p

    er 1

    00,0

    00 p

    eopl

    e in

    Indi

    a

    ScenarioCautious return

    Moderate return

    Normal (pre−intervention)

    Soc. Dist. + Travel Ban

    as of 07 April, 2020Predicted number of new COVID−19 cases in India under hypothetical scenarios

    © COV−IND−19 Study Group

    Cautious 5/15: 1,053 Cautious 6/15: 16,298 Cautious 7/15: 25,503

  • Long term – slow adherence

    30

    Difference between social distancing andcautious return on May 15: 438,789 cases

    Difference between social distancing andcautious return on June 15: 3,369,834 cases

    Difference between social distancing andcautious return on July 15: 6,403,186 cases

    0

    200

    400

    600

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f inf

    ecte

    d ca

    ses

    per 1

    00,0

    00 p

    eopl

    e in

    Indi

    a ScenarioCautious return

    Moderate return

    Normal (pre−intervention)

    Soc. Dist. + Travel Ban

    as of 07 April 2020Predicted number of COVID−19 cases in India under hypothetical scenarios

    © COV−IND−19 Study Group

    Cautious 5/15: 17,477 Cautious 6/15: 188,249 Cautious 7/15: 812,795

  • Long term – slow adherence

    31

    Difference between social distancing andcautious return on May 15: 49,188 cases

    Difference between social distancing andcautious return on June 15: 115,025 cases

    Difference between social distancing andcautious return on July 15: 83,560 cases

    0

    3

    6

    9

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f new

    cas

    es p

    er 1

    00,0

    00 p

    eopl

    e in

    Indi

    a

    ScenarioCautious return

    Moderate return

    Normal (pre−intervention)

    Soc. Dist. + Travel Ban

    as of 07 April, 2020Predicted number of new COVID−19 cases in India under hypothetical scenarios

    © COV−IND−19 Study Group

    Cautious 5/15: 699 Cautious 6/15: 12,887 Cautious 7/15: 26,012

  • 7.89Q5;

  • Takeaway messages• High uncertainty in predicted numbers (note large upper credible limit)

    • Variation in predictions increases as we go further in time

    • Outputs change everyday and data trumps models

    • Relative comparison of interventions are still meaningful

    • Need some form of suppression in place post-lockdown (cautious return)

    • A rigorous lens to quantify the pulse and movements of an epidemic but an incomplete description of the costs of interventions and what society is undergoing as a whole

    33

  • 9'(9%403()$+/D(40##"$"%)U

    2"

    3 day

    s

    6 days

    14 days

    100

    1,000

    10,000

    100,000

    1,000,000

    100

    1,000

    10,000

    100,000

    1,000,000

    0 20 40 60Days since cases reached 100

    Cum

    ulat

    ive n

    umbe

    r of c

    ases

    CountryChina

    France

    Germany

    India

    Iran

    Italy

    South Korea

    US

  • Hypotheses• Limited Testing, Testing Strategy and Criteria

    • Reporting of deaths

    • Temperature

    • BCG vaccinations, use of antimalarials, genetics, immunity

    • Younger population

    35

    \

    https://www.medrxiv.org/content/10.1101/2020.04.01.20049478v1

  • 2$2$%&'()*+,!""#$%&&;/7-"!/*"5-/4!"(,3+&;-)".*-$&,3*32)7/*.$1,)$-1,3.2"$1)*-1+-)2/240-$$&

    https://fivethirtyeight.com/features/coronavirus-case-counts-are-meaningless/

  • 37

    30 March 2020 Imperial College COVID-19 Response Team

    DOI: https://doi.org/10.25561/77731 Page 1 of 35

    Estimating the number of infections and the impact of non-pharmaceutical interventions on COVID-19 in 11 European countries Seth Flaxman*, Swapnil Mishra*, Axel Gandy*, H Juliette T Unwin, Helen Coupland, Thomas A Mellan, Harrison Zhu, Tresnia Berah, Jeffrey W Eaton, Pablo N P Guzman, Nora Schmit, Lucia Cilloni, Kylie E C Ainslie, Marc Baguelin, Isobel Blake, Adhiratha Boonyasiri, Olivia Boyd, Lorenzo Cattarino, Constanze Ciavarella, Laura Cooper, Zulma Cucunubá, Gina Cuomo-Dannenburg, Amy Dighe, Bimandra Djaafara, Ilaria Dorigatti, Sabine van Elsland, Rich FitzJohn, Han Fu, Katy Gaythorpe, Lily Geidelberg, Nicholas Grassly, Will Green, Timothy Hallett, Arran Hamlet, Wes Hinsley, Ben Jeffrey, David Jorgensen, Edward Knock, Daniel Laydon, Gemma Nedjati-Gilani, Pierre Nouvellet, Kris Parag, Igor Siveroni, Hayley Thompson, Robert Verity, Erik Volz, Caroline Walters, Haowei Wang, Yuanrong Wang, Oliver Watson, Peter Winskill, Xiaoyue Xi, Charles Whittaker, Patrick GT Walker, Azra Ghani, Christl A. Donnelly, Steven Riley, Lucy C Okell, Michaela A C Vollmer, Neil M. Ferguson1 and Samir Bhatt*1

    Department of Infectious Disease Epidemiology, Imperial College London Department of Mathematics, Imperial College London WHO Collaborating Centre for Infectious Disease Modelling MRC Centre for Global Infectious Disease Analysis Abdul Latif Jameel Institute for Disease and Emergency Analytics, Imperial College London Department of Statistics, University of Oxford *Contributed equally 1Correspondence: [email protected], [email protected]

    Summary Following the emergence of a novel coronavirus (SARS-CoV-2) and its spread outside of China, Europe is now experiencing large epidemics. In response, many European countries have implemented unprecedented non-pharmaceutical interventions including case isolation, the closure of schools and universities, banning of mass gatherings and/or public events, and most recently, widescale social distancing including local and national lockdowns.

    In this report, we use a semi-mechanistic Bayesian hierarchical model to attempt to infer the impact of these interventions across 11 European countries. Our methods assume that changes in the reproductive number a measure of transmission - are an immediate response to these interventions being implemented rather than broader gradual changes in behaviour. Our model estimates these changes by calculating backwards from the deaths observed over time to estimate transmission that occurred several weeks prior, allowing for the time lag between infection and death.

    One of the key assumptions of the model is that each intervention has the same effect on the reproduction number across countries and over time. This allows us to leverage a greater amount of data across Europe to estimate these effects. It also means that our results are driven strongly by the data from countries with more advanced epidemics, and earlier interventions, such as Italy and Spain. We find that the slowing growth in daily reported deaths in Italy is consistent with a significant impact of interventions implemented several weeks earlier. In Italy, we estimate that the effective reproduction number, Rt, dropped to close to 1 around the time of lockdown (11th March), although with a high level of uncertainty.

    Overall, we estimate that countries have managed to reduce their reproduction number. Our estimates have wide credible intervals and contain 1 for countries that have implemented all interventions considered in our analysis. This means that the reproduction number may be above or below this value. With current interventions remaining in place to at least the end of March, we estimate that interventions across all 11 countries will have averted 59,000 deaths up to 31 March [95% credible interval 21,000-120,000]. Many more deaths will be averted through ensuring that interventions remain in place until transmission drops to low levels. We estimate that, across all 11 countries between 7 and 43 million individuals have been infected with SARS-CoV-2 up to 28th March, representing between 1.88% and 11.43% of the population. The proportion of the population infected

    Source: https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf/

    https://www.imperial.ac.uk/media/imperial-college/medicine/sph/ide/gida-fellowships/Imperial-College-COVID19-Europe-estimates-and-NPI-impact-30-03-2020.pdf/

  • ,-./012 345.61-71./6.6189:14-.1;/1.>1?-@4.=5/6A2 &/0)123B@8@>9.5C/1.-.9>1./6.61D/=185>>5-41E1B@8@>9.5C/1?-475=8/F1?96/61D/=185>>5-42 GFH@6./F1IJ6K@9=/FL*A)%# %&'()*+,!""#$%&&3.*'3*06/26)")(3*4&,37/61"-$"/24F,,37/689/26/)(3*4

    https://ourworldindata.org/covid-testinghttp://covid19india.org/

  • 0

    20000

    40000

    60000

    80000

    100000

    120000

    140000

    3/6/2020

    3/7/2020

    3/8/2020

    3/9/2020

    3/10/2020

    3/11/2020

    3/12/2020

    3/13/2020

    3/14/2020

    3/15/2020

    3/16/2020

    3/17/2020

    3/18/2020

    3/19/2020

    3/20/2020

    3/21/2020

    3/22/2020

    3/23/2020

    3/24/2020

    3/25/2020

    3/26/2020

    3/27/2020

    3/28/2020

    3/29/2020

    3/30/2020

    3/31/2020

    4/1/2020

    4/2/2020

    US

    PositiveIncrease NegativeIncrease

    Average positive rate 0.151

    Highest positive rate 0.315

    US daily tests versus daily incidence

    Source: https://ourworldindata.org/covid-testing; covid19india.org

    https://ourworldindata.org/covid-testinghttp://covid19india.org/

  • 0

    2000

    4000

    6000

    8000

    10000

    12000

    1/31/2020

    2/2/2020

    2/4/2020

    2/6/2020

    2/8/2020

    2/10/2020

    2/12/2020

    2/14/2020

    2/16/2020

    2/18/2020

    2/20/2020

    2/22/2020

    2/24/2020

    2/26/2020

    2/28/2020

    3/1/2020

    3/3/2020

    3/5/2020

    3/7/2020

    3/9/2020

    3/11/2020

    3/13/2020

    3/15/2020

    3/17/2020

    3/19/2020

    3/21/2020

    3/23/2020

    3/25/2020

    3/27/2020

    3/29/2020

    3/31/2020

    4/2/2020

    UK

    PositiveIncrease NegativeIncrease

    UK daily tests versus daily incidence

    Source: https://ourworldindata.org/covid-testing; covid19india.org

    Average positive rate 0.078

    Highest positive rate 0.423

    https://ourworldindata.org/covid-testinghttp://covid19india.org/

  • 0

    2000

    4000

    6000

    8000

    10000

    12000

    14000

    16000

    18000

    20000

    1/22/2020

    1/24/2020

    1/26/2020

    1/28/2020

    1/30/2020

    2/1/2020

    2/3/2020

    2/5/2020

    2/7/2020

    2/9/2020

    2/11/2020

    2/13/2020

    2/15/2020

    2/17/2020

    2/19/2020

    2/21/2020

    2/23/2020

    2/25/2020

    2/27/2020

    2/29/2020

    3/2/2020

    3/4/2020

    3/6/2020

    3/8/2020

    3/10/2020

    3/12/2020

    3/14/2020

    3/16/2020

    3/18/2020

    3/20/2020

    3/22/2020

    3/24/2020

    3/26/2020

    3/28/2020

    3/30/2020

    4/1/2020

    4/3/2020

    South Korea

    PositiveIncrease NegativeIncrease

    South Korea daily tests versus daily incidence

    Source: https://ourworldindata.org/covid-testing; covid19india.org

    Average positive rate 0.021

    Highest positive rate 0.111

    https://ourworldindata.org/covid-testinghttp://covid19india.org/

  • 0

    200

    400

    600

    800

    1000

    1200

    1400

    1600

    1800

    2000

    2/27/2020

    2/28/2020

    2/29/2020

    3/1/2020

    3/2/2020

    3/3/2020

    3/4/2020

    3/5/2020

    3/6/2020

    3/7/2020

    3/8/2020

    3/9/2020

    3/10/2020

    3/11/2020

    3/12/2020

    3/13/2020

    3/14/2020

    3/15/2020

    3/16/2020

    3/17/2020

    3/18/2020

    3/19/2020

    3/20/2020

    3/21/2020

    3/22/2020

    3/23/2020

    3/24/2020

    3/25/2020

    3/26/2020

    3/27/2020

    3/28/2020

    3/29/2020

    3/30/2020

    3/31/2020

    4/1/2020

    4/2/2020

    Iceland

    PositiveIncrease NegativeIncrease

    Iceland daily tests versus daily incidence

    Source: https://ourworldindata.org/covid-testing; covid19india.org

    Average positive rate 0.079

    Highest positive rate 0.350

    https://ourworldindata.org/covid-testinghttp://covid19india.org/

  • India daily tests versus daily incidence

    0

    2000

    4000

    6000

    8000

    10000

    12000

    14000

    16000

    3/19/2020

    3/20/2020

    3/21/2020

    3/22/2020

    3/23/2020

    3/24/2020

    3/25/2020

    3/26-3/27/2020

    3/28-4/1/2020

    4/2/2020

    4/3/2020

    4/4/2020

    4/5/2020

    4/6/2020

    4/7/2020

    4/8/2020

    Source: https://ourworldindata.org/covid-testing; covid19india.org

    Average positive rate 0.04

    Highest positive rate 0.07

    https://ourworldindata.org/covid-testinghttp://covid19india.org/

  • Summer Boon?

    44

    Month Correlation 95% Confidence Interval

    Countries with non-zero incidence

    January -0.185 [-0.55, 0.24] 24

    February -0.110 [-0.362, 0.157] 56

    March -0.173 [-0.314, -0.026] 175

  • "#

    K(+)'2L&!""#$%&&!'()"!*'("!'+,-$&./01'23"4#56()

    =#"0>(,-$-($%('7-#:($7:(,"#:-#:($&-'3#

    K(+)'2L&!""#$%&&***,7007)',60/&608519:&/0;5)5"4&

    https://healthweather.us/%3Fmode=Atypicalhttps://www.google.com/covid19/mobility/

  • Summary (as data scientists)

    • Public health and economics are at a competing interest

    • Use of data (mobile network, hospital admissions, temperature maps) to chase the epidemic and nip it in the bud

    • Nimble policymaking (pause, push and drive) in a data adaptive way

    • Use data to estimate need, deploy resources, how many beds, PPE, ICU beds, ventilators are needed and where?

    46

  • "-"-

  • Austrian Poet Rainer Maria Rilke said, “Let everything happen to you. The beauty and the terror. Just keep going. No feeling is final.”

  • T23%-(X*+(3%4(=/"3'"(H)3D(H3#"G(H)3D(F*B"S

    "/

  • Back up slides: Length of lockdown

    50

  • R0 under lockdown length scenarios

    51

    Lockdown begins Lockdown ends

    0.0

    0.5

    1.0

    1.5

    2.0

    Mar 01 Apr 01 May 01 Jun 01 Jul 01Date

    Impl

    ied

    R0

    Scenario

    21−day lockdown

    28−day lockdown

    42−day lockdown

    56−day lockdown

    as of 07 April, 2020

    R0 over time by scenario

    © COV−IND−19 Study Group

    Lockdown begins Lockdown ends

    0.0

    0.5

    1.0

    1.5

    2.0

    Mar 01 Apr 01 May 01 Jun 01 Jul 01Date

    Impl

    ied

    R0

    Scenario

    21−day lockdown

    28−day lockdown

    42−day lockdown

    56−day lockdown

    as of 07 April, 2020

    R0 over time by scenario

    © COV−IND−19 Study Group

  • Lockdown lengths – quick adherence

    52

    0

    50

    100

    150

    200

    250

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f inf

    ecte

    d ca

    ses

    per 1

    00,0

    00 p

    eopl

    e in

    Indi

    a Scenario21−day lockdown

    28−day lockdown

    42−day lockdown

    56−day lockdown

    as of 07 April, 2020Predicted number of COVID−19 infections under varying lockdown lengths

    © COV−IND−19 Study Group

  • Lockdown lengths – quick adherence

    53

    0

    1

    2

    3

    4

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f inf

    ecte

    d ca

    ses

    per 1

    00,0

    00 p

    eopl

    e in

    Indi

    a Scenario21−day lockdown

    28−day lockdown

    42−day lockdown

    56−day lockdown

    as of 07 April, 2020Predicted number of daily COVID−19 infections under varying lockdown lengths

    © COV−IND−19 Study Group

  • Lockdown lengths – slow adherence

    54

    0

    50

    100

    150

    200

    250

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f inf

    ecte

    d ca

    ses

    per 1

    00,0

    00 p

    eopl

    e in

    Indi

    a Scenario21−day lockdown

    28−day lockdown

    42−day lockdown

    56−day lockdown

    as of 07 April, 2020Predicted number of COVID−19 infections under varying lockdown lengths

    © COV−IND−19 Study Group

  • Lockdown lengths – slow adherence

    55

    0

    1

    2

    3

    4

    May 0

    1

    Jun 0

    1Ju

    l 01

    Aug 0

    1

    Date

    Num

    ber o

    f inf

    ecte

    d ca

    ses

    per 1

    00,0

    00 p

    eopl

    e in

    Indi

    a Scenario21−day lockdown

    28−day lockdown

    42−day lockdown

    56−day lockdown

    as of 07 April, 2020Predicted number of daily COVID−19 infections under varying lockdown lengths

    © COV−IND−19 Study Group

  • A Conceptual Model

    56

    S E R

    A = AUT + ATFN

    I = ITTP + ITFP

    Unreported, untested cases plus false negative tests

    Tested and reported

    Managed at home Hospitalized

    ICU: severe disease

    DeathNon random samplingWho are we testing?

    Title slide WebinarNCAER_COVIND19_Slides